A brief history of PCR discovery {#S0001}
================================

There are very few inventions that can compete with the importance of PCR over the past 100 years as it revolutionized biological and genetic research. Mullis noticed that the Sanger sequencing method \[[@B1]\] yielded weak signals while sequencing a single copy gene due to insufficient concentration of DNA. Adding a denaturation step to split each dsDNA molecule into two ssDNAs, and a reverse primer to define the total amplicon length, resulted in the amplification of the DNA copies by two \[[@B2],[@B3]\]. Unfortunately, the polymerase was destroyed in each denaturation step and had to be added for each PCR cycle, making the method implementation tedious; this was resolved by an automated system called 'Baby Blue' ([Figure 1](#F1){ref-type="fig"}A).

![The development of the PCR system and its applications.\
**(A)** A prototype PCR thermal cycler developed by Cetus Corporation in 1986, which is the first model embedding the software cycling controller in the thermal cycling block. **(B)** Space-domain PCR. **(C)** Time-domain PCR. **(D)** Use of anchored allele-specific probes and labeled primers for the colorimetric detection of mutations in the *HBB* gene. **(E)** One of the first applications of multiplex PCR, the detection of deletions in the *DMD* gene in patients affected by Duchenne muscular dystrophy. **(F)** A recent version of the multiplex PCR with fluorescent-labeled primers and separation of amplicons using capillary electrophoresis currently used in routine forensic analysis. **(G)** The use of PCR for the amplification of alleles of a multiallelic minisatellite locus, silver staining of amplicons in a polyacrylamide gel, and the comparison of their lengths with an allele marker, a ladder.\
Reproduced with permission from \[[@B4]\].](figure1){#F1}

Utilization of polymerase from the bacteria *Thermophilus aquaticus* (Taq polymerase) \[[@B8]\], capable of surviving temperatures of 94°C, eliminated the necessary addition of fresh polymerase. An automated time domain temperature cycler with a stationary sample was also assembled \[[@B9]\], with Southern blotting used to detect the PCR product \[[@B10]\]. Another cycler with three zones, each with a different temperature and the sample being moved between, is called the 'space-domain system' ([Figure 1](#F1){ref-type="fig"}B). Currently, the time domain systems are more common ([Figure 1](#F1){ref-type="fig"}C).

The history of PCR application in bioscience {#S0002}
============================================

Originally, PCR was developed for the detection of mutations in the *HBB* gene that causes sickle cell anemia. The hybridization of radioactive-labeled oligonucleotides and the subsequent restriction analysis were used in this project to search for such inherited mutations. Therefore, the sequences of the β-globin gene were selected as the first for enzymatic amplification \[[@B3],[@B11]\].

The knowledge gained during this work on the *HBB* gene \[[@B12]\] was utilized in the analysis of alleles of *HLA-DQ* ([Figure 1](#F1){ref-type="fig"}D) and resulted in the development of a genotyping method for this multiallelic locus using the hybridization of amplicons with allele-specific oligonucleotides \[[@B13]\]. The technique was applied in transplantology and forensic science. Numerous clinical applications of PCR followed especially in the field of clinical genetics \[[@B14],[@B15]\] and in microbiology for the detection of viral and bacterial infections \[[@B16]\]. The usefulness of PCR as a tool for infectious disease diagnosis was first demonstrated in detection \[[@B19]\] in 1987 and further elaborated in later years \[[@B20],[@B21]\].

The finding that amplicons of different lengths determined by different primer pairs might be produced simultaneously in one PCR tube represented an important milestone in the development of PCR diagnostic approaches. This is the so-called multiplex PCR, which was used during early PCR development for the detection of deletions in *DMD* -- one of the largest human genes ([Figure 1](#F1){ref-type="fig"}E) \[[@B5]\]. This gene is localized on the X-chromosome and its mutations are responsible for Duchenne--Becker muscular dystrophy in males. Until recently, numerous diagnostic approaches were based on this principle, such as the simultaneous detection of *F2* polymorphism and the* F5* Leiden mutation \[[@B22]\]. Recently, the preparation of libraries of large gene panels for next-generation sequencing (NGS) has also been based on highly multiplexed PCR \[[@B23],[@B24]\].

After the publication of the pioneer study in which amplification of DNA from single sperm cells was demonstrated \[[@B25]\], a new area of PCR applications began. This pioneering development led to the recent broad uses of PCR in forensic science and assisted reproduction, where the analysis of genetic material from one or a few cells is required.

PCR entered the field of forensic science when researchers successfully demonstrated the multiplexing of six highly polymorphic minisatellite loci in one PCR tube \[[@B26]\]. This success came with high reproducibility of results obtained from nanogram quantities of human DNA. Further elaboration of these principles led to the introduction of multiplexed microsatellite analysis, silver staining of amplicons in a polyacrylamide gel and the comparison of their lengths with an allele marker, a ladder ([Figure 1](#F1){ref-type="fig"}G) \[[@B27]\]. This was followed by the separation of fluorescent-labeled amplicons by capillary electrophoresis. This development allowed scientists to work with shorter amplicon lengths and analyze the highly degraded material \[[@B28]\]. This methodology currently represents the basic workflow in forensic laboratories ([Figure 1](#F1){ref-type="fig"}F) \[[@B6]\].

Since 1993, following the development of a method for monitoring PCR kinetics in real time \[[@B29]\], PCR techniques became fully quantitative (qPCR). The incorporation of reverse transcription (RT) as the first step before thermal cycling allowed the use of PCR technologies (RT-PCR or qRT-PCR) in RNA studies \[[@B30],[@B31]\]. These modifications of the basic PCR technique quickly became the gold standard for quantitative analysis of nucleic acids \[[@B32]\]. Until now, we had three basic systems: end-point PCR, qPCR and digital PCR (dPCR) ([Figure 2](#F2){ref-type="fig"}A) \[[@B33]\]. However, there are many other variants of basic PCR techniques, one of which is bridge PCR ([Figure 2](#F2){ref-type="fig"}B) \[[@B34]\].

![Current examples of commercially available techniques: quantitative PCR, droplet-based digital PCR, crystal digital PCR (cdPCR), PCR, bridge PCR for next-generation sequencing and sequencing of mRNA from individual cells using microfluidics.\
**(A)** A comparison of end-point PCR, qPCR and ddPCR. **(B)** Schematic representation of the principle of solid phase bridge DNA amplification. **(C)** Different techniques for splitting of samples. **(D)** Crystal droplet PCR -- formation of droplet crystals. **(E)** PCR and droplet-based library generation for single-cell RNA sequencing.\
ddPCR: Droplet-based digital PCR; qPCR: Quantitative PCR.\
**(A)** Reproduced with permission from \[[@B33]\]. **(B)** Reproduced with permission from \[[@B34]\], © Elsevier BV (2014).](figure2){#F2}

PCR miniaturization history based on a microfluidic platform {#S0003}
============================================================

The implementation of microfluidic systems led to the development of an entirely new family of devices, such as flow-through miniaturized and fast PCR, first using a space-domain system as seen in the very early cyclers \[[@B35]\]. Researchers involved in silicon micromachining quickly took up this challenge, developing miniaturized \[[@B36]\] and portable end point PCR and then qPCR devices.

Droplet-based systems {#S0004}
---------------------

There are several techniques that split samples to form droplets ([Figure 2](#F2){ref-type="fig"}C) \[[@B37]\]. The droplets, including cells, are loaded into the microfluidic channel and transferred to different positions within the chip, then subjected to a series of procedures such as cell lysis, DNA extraction and purification, PCR and fluorescence detection. The droplets with extracted DNA, in a small volume of a few nanoliters, are separated by an immiscible liquid, such as mineral oil, forming an emulsion. Then the thermal cycling is conducted by heating this emulsion and cameras capture the subsequent fluorescence \[[@B38]\]. This platform is commonly used in single-cell studies, often termed 'single-cell PCR' \[[@B39]\].

Chip-based systems {#S0005}
------------------

A variety of chip structures are fabricated by micromachining with different wells or microfluidic channels in materials such as silicon, glass or polymers, typically polydimethylsiloxane or polymethylmethacrylate. Samples are loaded into either wells or channels for subsequent DNA amplification by PCR \[[@B40]\]. Miniaturized PCR systems provide portability and save time. The total reaction time depends on a series of parameters such as chip size, PCR master mix volume, the thermal conductivity of the substrate and the temperature cycling rate. Researchers successfully shortened the reaction time and demonstrated an extremely fast PCR with 0.4 s/cycle, resulting in total reaction time in less than 15 s \[[@B41]\].

Hybrid systems {#S0006}
--------------

Alternatively, the PCR master mix is dispensed in a stationary place such as a hydrophobic/oleophobic glass coverslip and covered by mineral oil, forming a virtual reaction chamber \[[@B42]\] using a donut-shaped micro heater to conduct the thermal cycling beneath the virtual reaction chamber and utilizing a passive cooling method. This heating/cooling system integrated with a fluorescence optical detection method was a core of the smallest qPCR performing an amplification of cDNA from H7N9 avian influenza virus \[[@B43]\] and RT-PCR of Ebola virus RNA \[[@B44]\].

Technologies that evolved from & were inspired by PCR {#S0007}
=====================================================

Digital PCR {#S0008}
-----------

Many technologies have evolved from original PCR; one example is dPCR \[[@B45]\], which is based on splitting a PCR sample into thousands, in some cases millions, of subsamples from the original to digitize the pool of DNA molecules having either a single or no copy in each subsample. dPCR is always based on microfluidics and it is either droplet based or chip based. dPCR is capable of determining the absolute quantification of the DNA/RNA copy number, avoiding time-consuming quantification by qPCR based on standard curves. It also allows multiplex PCR to amplify the number of copies of DNA samples with unfavorable ratios between abundant and rare DNAs.

### Droplet-based digital PCR (ddPCR) {#S0009}

The sample passes through the microfluidic chip forming a type of segmented flow, where the sample is split into tens of thousands of droplets separated by an immiscible liquid, such as mineral oil forming an emulsion \[[@B10]\]. The emulsion is collected in a vial, PCR is performed and the sample is subsequently processed by flow cytometer to count the number of droplets with positive PCR. Alternatively, the emulsion is fed into a plastic chip forming a single layer of droplets. The thermal cycling is conducted and a fluorescent image of the droplets is captured and evaluated ([Figure 2](#F2){ref-type="fig"}D) \[[@B46]\]. Compared with qPCR, ddPCR has the advantages of higher precision and a lower coefficient of variation in absolute quantification \[[@B47]\]. The PCR multiplexing is typically conducted by probe-based fluorescence with different excitation colors for each DNA/RNA. It is also used to generate libraries for single-cell RNA sequencing ([Figure 2](#F2){ref-type="fig"}E) \[[@B39]\].

### Chip-based digital PCR (cdPCR) {#S0010}

The sample is loaded into silicon chips with wells made by a micromachining technique. Then the thermal cycling is performed and the chip is imaged by fluorescence microscopy \[[@B48]\] to determine the number of wells with positive PCR results \[[@B49]\]. Multiplexing is also performed in the same way as in ddPCR \[[@B50]\]. The silicon-based microfabrication allows the combination of cdPCR integrated with a heater/sensor using an ion-sensitive field-effect transistor in each well to monitor the PCR, eliminating the need for a separate fluorescence imaging system \[[@B51]\].

Isothermal amplification {#S0011}
------------------------

qPCR is conducted by thermal cycling and its rate is typically limited by sample cooling, which slows with increased sample volumes. The commercial utilization of PCR was limited for several years by patent protection granted to Cetus Corporation (later sold to Chiron Corporation; CA, USA). Researchers tried to overcome problems related to cooling and bypassing the patent protection by creating new nucleic acid amplification methods. The isothermal amplification overcomes the cooling problems because it requires no cooling process. Several techniques were developed with isothermal amplification, such as loop-mediated isothermal amplification (LAMP) \[[@B52]\] and recombinase polymerase amplification \[[@B53]\], which are currently popular. Isothermal nucleic acid amplification requires no temperature cycling and has an advantage of simpler device design with lower power consumption in comparison with fast PCR. LAMP achieves high specificity by using up to six primers to identify up to eight DNA sequences of the target. The introduction of different isothermal amplification techniques also led to the development of new approaches for visualization of amplification products and for monitoring reaction kinetics independently of exonuclease activity of DNA polymerase that is employed in qPCR with TaqMan probes. The systems involving clusters of regularly interspaced short palindromic repeats (CRISPR), with a CRISPR-associated protein known as CAS, for the detection of isothermal amplification products were developed \[[@B54],[@B55]\] and used also for the detection of variant sequences in amplicons obtained by PCR \[[@B56]\].

PCR for other applications {#S0012}
==========================

There are modern techniques where PCR is indispensable and some examples are platforms for NGS \[[@B57]\]. The Illumina platform uses the modified PCR to prepare clusters of single-molecule DNA templates each containing approximately 1000 DNA copies \[[@B58]\]. The Ion Torrent technology detects the protons released as nucleotides are incorporated during new DNA strand synthesis. The DNA fragments for sequencing on this platform are linked with specific adapters and then amplified by emulsion PCR on the surface of 3-micron-diameter beads \[[@B59]\].

Outstanding challenges in PCR {#S0013}
=============================

Despite the great diagnostic potential of PCR, the success of each of its practical applications is highly dependent on the quality of samples containing nucleic acids for amplification. The spectrum of different inhibitors of PCR complicating the work in real-world samples, such as false-negative results or higher limits of detection, have been characterized \[[@B60]\]. Procedures leading to sufficient purification of samples \[[@B61],[@B62]\] and to the development of inhibition-resistant DNA polymerases \[[@B63]\] have been developed. It has been documented that dPCR is more resistant to the presence of inhibitors \[[@B60]\].

Additionally, the successful PCR amplification of GC-rich DNA sequences represent another challenge. It is complicated by the generation of secondary structures hindering full denaturation and primer annealing and represents multiple techniques to overcome this problem have been established \[[@B64],[@B65]\].

The miniaturization of PCR devices highlighted another challenge, which should be solved preanalytically to achieve sensitivity comparable to established laboratories. Miniaturized devices work with low-volume samples and therefore the real-world biological samples should be effectively isolated and preconcentrated, respectively, prior to analysis with such devices.

PCR commercialization: history & success {#S0014}
========================================

There are two aspects to the commercialization efforts that have made PCR a gold standard in molecular diagnostics. One is the development of an automated instrument replacing manual operations and the other is the set of reagents that increase the PCR's specificity, eliminating cross-contamination and inhibition, reducing reaction time and increasing multiplexing capability.

The first company that took the technique into full-fledged commercialization based its technique on Cetus' original work. Later, many companies started to tackle the different aspects of the PCR system.

With the trend of miniaturization and point-of-care (POC) testing, there was also developments in PCR systems based on microfluidic platforms \[[@B42],[@B44]\]. Cepheid, with their GeneXpert, created a unique system capable of performing sample-to-answer operation proven for the diagnosis of *Bacillus anthraxes* at US mail stations and HIV/tuberculosis in South Africa.

The most significant success of the miniaturization and utilization of microfluidics is dPCR, a technique enabled by microfluidics. Both droplet- and chip-based systems were commercialized with the number of subsamples (wells) above 1 million.

Conclusion & future perspective {#S0015}
===============================

There are several techniques, such as NGS, where PCR plays an indispensable role and this role will be strengthened in the foreseeable future. PCR will play a major role in future molecular diagnostic techniques. We can envision the use of microfluidics performing parallel multiple sample analysis using handheld POC systems. The microfluidic devices will also be able to perform RT-PCR to analyze immunomagnetic exosomal RNA ([Figure 3](#F3){ref-type="fig"}A) \[[@B40]\]. Droplet-based qPCR for single-cell mRNA purification and gene expression analysis will be another large application of microfluidics in the near future ([Figure 3](#F3){ref-type="fig"}B) \[[@B38]\], as well as miRNA quantitation assays ([Figure 3](#F3){ref-type="fig"}D) \[[@B66]\] and chip-based digital RT-PCR for absolute quantification of mRNA in single cells ([Figure 3](#F3){ref-type="fig"}C) \[[@B50]\]. Currently, the parallel sequencing of all RNA or DNA molecules belonging to a single cell inside a larger cell population is possible due to emulsion PCR ([Figure 2](#F2){ref-type="fig"}E), where the nucleic acids from each cell are enclosed in one droplet, barcoded and then amplified \[[@B39]\]. The only sequencing platform that bypasses PCR is the Oxford Nanopore system \[[@B67]\].

![Applications of microfluidics into massively parallel and handheld point-of-care systems.\
**(A)** Chip-based integrated real-time reverse transcription PCR platform for the analysis of the immunomagnetic exosomal RNA. **(B)** Droplet-based quantitative PCR for a single cell to mRNA purification and gene expression analysis. **(C)** Chip-based digital RT-PCR for absolutequantification of mRNA in single cells. **(D)** Droplet-based dPCR for miRNA quantitation assay. **(E)** Paper-based LAMP system made by polydimethylsiloxane for molecular diagnostics. **(F)** Forensic science, DNA profiles on a chip. **(G)** BioFire, detection of bacteria and viruses on a chip.\
Reproduced with permission from \[[@B38],[@B50],[@B68],[@B69]\].](figure3){#F3}

We also predict that paper-based systems for PCR or LAMP will be in high demand for molecular diagnostics ([Figure 3](#F3){ref-type="fig"}E) \[[@B70]\]. Forensic science will be routinely conducted on location at crime scenes performing DNA profiling on a chip ([Figure 3](#F3){ref-type="fig"}F) \[[@B71]\]. Detection systems are already commercially available, such as BioFire for the detection of bacteria and viruses on a chip.

Further, commercial products of such detection systems are already available, even though not many, such as BioFire, exist for the detection of bacteria and viruses on a chip ([Figure 3](#F3){ref-type="fig"}G) \[[@B69]\]. We predict that more microfluidic PCR-based systems will be developed and commercialized.

The miniaturization of PCR will continue with the development of new systems integrating sample preparation with the qPCR, moving toward truly portable sample-to-answer systems for POC applications. The COVID pandemic sped up this development, causing a boom in POC systems by converting existing devices such as LAMP-based ID NOW originally developed for influenza into a SARS-CoV-2 diagnostic tool by changing primers \[[@B72],[@B73]\]. There will likely be more POC devices developed for SARS-CoV-2 and later converted into diagnostics for other RNA viruses. As of 26 May 2020, there are 81 kits and systems approved by the US FDA under 'emergency use authorizations', with most based on molecular biology, typically using real-time RT-PCR \[[@B74]\]. Further elaboration of CRISPR-based methods \[[@B55],[@B56]\] to detect and differentiate amplification products can be expected, as this methodology has successfully been applied in various fields of biology.

The diagnoses systems could eventually be linked together forming an 'internet of things', as demonstrated in PCR previously. The new systems could be standalone or based on a smart phone with an Android operating system \[[@B75]\]. It has an advantage that the camera can be either controlled externally or internally and it can communicate with the temperature and illumination control via Bluetooth. Once the image is captured, the Android system could process it and send it to a control center via a wireless network \[[@B76]\]. There are portable systems besides PCR that might be used; other DNA multiplication techniques, such as LAMP and recombinase polymerase amplification are more energy efficient than PCR.

We can also envision portable dPCR systems with fast turnaround for clinical diagnostics \[[@B77]\], forensic science \[[@B71],[@B78]\] and environmental research, avoiding time-consuming sample transfer to large facilities that risks sample degradation.
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